Notably, if vessel co-option was described in Olig2/Wnt7+ GBM cells as an intrinsic and acquired resistance mechanism to anti-angiogenesis20, here we discovered that vessel co-option in AC/MES-like cells is an intrinsic and acquired resistance mechanism to conventional therapy. The gene discussed is OLIG2; the disease is glioblastoma.